Asia Pacific Newborn Screening Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Description
Asia Pacific Newborn Screening Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Newborn screening has evolved from a simple urine or blood screening test to a more comprehensive and complex screening system capable of detecting over 50 different conditions. Newborn screening tests measure a number of markers in infant’s blood that can be either decreased or increased if an infant has certain diseases. Currently, conditions such as cystic fibrosis (CF), congenital hypothyroidism, phenylketonuria (PKU), and around 22 other metabolic conditions that affect protein or fat metabolism can be diagnosed through newborn screening tests.
Market Dynamics
Demand for newborn screening is increasing in order to tackle various infectious diseases such as measles, mumps, polio, tuberculosis, rubella, influenza, whooping cough, chickenpox, malaria, and streptococcal pharyngitis. According to the World Health Organization (WHO) 2018, globally, around 86% of infants are vaccinated against 26 diseases, however, 19.5 million infants are unvaccinated resulting in death of 2-3 million children every year.
Screening of newborn is rapidly gaining traction in Asia Pacific region, owing to highest birth rate in the region, which is almost half of the global population. Therefore, countries in Asia Pacific are focusing on arranging various workshops to discuss and find solutions for increasing incidence of neonatal diseases. For instance, from March 30–April 1, 2008, PerkinElmer, Inc. arranged a workshop on consolidating newborn screening efforts in Cebu, Philippines, in Asia Pacific region. From June 4-5 in 2010, PerkinElmer, Inc. arranged another workshop in Manila, Philippines, which included workshop participants such as service providers, policy-makers, consumer advocates, and researchers from 11 different countries.
Key features of the study:
This report provides in-depth analysis of the Asia Pacific newborn screening market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the Asia Pacific newborn screening market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Medtronic plc, Agilent Technologies, Waters Technologies Corporation, AB SCIEX, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc., Trivitron Healthcare Pvt. Ltd., and ZenTech S.A.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The Asia Pacific newborn screening market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for Asia Pacific newborn screening market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Asia Pacific Newborn Screening Market, By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
Asia Pacific Newborn Screening Market, By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
Asia Pacific Newborn Screening Market, By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Asia Pacific Newborn Screening Market, By Region:
China
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
India
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Japan
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Australia
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
South Korea
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
ASEAN
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Rest of Asia Pacific
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Company Profiles
Medtronic plc*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Bio-rad Laboratories, Inc.
GE Healthcare
PerkinElmer, Inc.
Waters Technologies Corporation
Masimo Corporation
Natus Medical Inc.
Trivitron Healthcare Pvt. Ltd.
ZenTech S.A.
Agilent Technologies, Inc.
Danaher Corporation (AB SCIEX)
“*” marked represents similar segmentation in other categories in the respective section.
Newborn screening has evolved from a simple urine or blood screening test to a more comprehensive and complex screening system capable of detecting over 50 different conditions. Newborn screening tests measure a number of markers in infant’s blood that can be either decreased or increased if an infant has certain diseases. Currently, conditions such as cystic fibrosis (CF), congenital hypothyroidism, phenylketonuria (PKU), and around 22 other metabolic conditions that affect protein or fat metabolism can be diagnosed through newborn screening tests.
Market Dynamics
Demand for newborn screening is increasing in order to tackle various infectious diseases such as measles, mumps, polio, tuberculosis, rubella, influenza, whooping cough, chickenpox, malaria, and streptococcal pharyngitis. According to the World Health Organization (WHO) 2018, globally, around 86% of infants are vaccinated against 26 diseases, however, 19.5 million infants are unvaccinated resulting in death of 2-3 million children every year.
Screening of newborn is rapidly gaining traction in Asia Pacific region, owing to highest birth rate in the region, which is almost half of the global population. Therefore, countries in Asia Pacific are focusing on arranging various workshops to discuss and find solutions for increasing incidence of neonatal diseases. For instance, from March 30–April 1, 2008, PerkinElmer, Inc. arranged a workshop on consolidating newborn screening efforts in Cebu, Philippines, in Asia Pacific region. From June 4-5 in 2010, PerkinElmer, Inc. arranged another workshop in Manila, Philippines, which included workshop participants such as service providers, policy-makers, consumer advocates, and researchers from 11 different countries.
Key features of the study:
This report provides in-depth analysis of the Asia Pacific newborn screening market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the Asia Pacific newborn screening market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Medtronic plc, Agilent Technologies, Waters Technologies Corporation, AB SCIEX, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc., Trivitron Healthcare Pvt. Ltd., and ZenTech S.A.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The Asia Pacific newborn screening market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for Asia Pacific newborn screening market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Asia Pacific Newborn Screening Market, By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
Asia Pacific Newborn Screening Market, By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
Asia Pacific Newborn Screening Market, By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Asia Pacific Newborn Screening Market, By Region:
China
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
India
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Japan
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Australia
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
South Korea
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
ASEAN
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Rest of Asia Pacific
By Product Type:
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry
Assay Kits and Reagents
By Test Type:
Phenylketonuria (PKU)
Critical Congenital Heart Defect (CCHD)
Hearing Screening
Sickle Cell Disease
Maple Syrup Urine Disease (MSUD)
Thyroid Disorder
Biotinidase Deficiency (BTD)
Others
By End User:
Hospitals
Maternity & Specialty Clinics
Diagnostic Centers
Company Profiles
Medtronic plc*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Bio-rad Laboratories, Inc.
GE Healthcare
PerkinElmer, Inc.
Waters Technologies Corporation
Masimo Corporation
Natus Medical Inc.
Trivitron Healthcare Pvt. Ltd.
ZenTech S.A.
Agilent Technologies, Inc.
Danaher Corporation (AB SCIEX)
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
193 Pages
- 1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Test Type
- Market Snippet, By End User
- Market Snippet, By Country
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Merger and Acquisition
- Technology Advancements
- Product Launches
- Government Initiatives
- Epidemiology
- Product Recalls
- Regulatory Scenario
- PORTER’S Five Forces
- PEST Analysis
- 4. Asia Pacific Newborn Screening Market, By Product Type, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hearing Screening Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Mass Spectrometer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Pulse Oximetry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Assay Kits and Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 5. Asia Pacific Newborn Screening Market, By Test Type, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Phenylketonuria (PKU)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Critical Congenital Heart Defect (CCHD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Hearing Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Sickle Cell Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Maple Syrup Urine Disease (MSUD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Thyroid Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Biotinidase Deficiency (BTD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 6. Asia Pacific Newborn Screening Market, By End User, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Maternity & Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 7. Asia Pacific Newborn Screening Market, By Region, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
- China
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- India
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Japan
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Australia
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- South Korea
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- ASEAN
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Rest of Asia Pacific
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Test Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- 8. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Medtronic plc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Bio-rad Laboratories, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- GE Healthcare
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- PerkinElmer, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Waters Technologies Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Masimo Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Natus Medical Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Trivitron Healthcare Pvt. Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- ZenTech S.A.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Agilent Technologies, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Danaher Corporation (AB SCIEX)
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Analyst Views
- 9. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 32 market data tables and 40 figures on “Newborn Screening Market” - Asia Pacific forecast to 2028”.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
